Chlamydia Trachomatis

Source of chlamydia reinfections may be GI tract

The current standard of care treatment for chlamydia sometimes fails to eradicate the disease, according to a review published ahead of print in Infection and Immunity, and the culprit may be in the gut.

Feb 06, 2014
popularity 5 / 5 (1) | comments 0 | with audio podcast

Breakthrough in treatment to prevent blindness

A UCSF study shows a popular treatment for a potentially blinding eye infection is just as effective if given every six months versus annually. This randomized study on trachoma, the leading cause of infection-caused ...

Dec 21, 2011
popularity 5 / 5 (1) | comments 0 | with audio podcast

Paternal exposures can adversely affect sperm

Acording to the California Teratogen Information Service (CTIS) Pregnancy Health Information Line, more studies are needed to evaluate men and the potential effect of illnesses, medications and lifestyle habits on fertility ...

Jun 20, 2011
popularity not rated yet | comments 0
  • Pages: 1

Chlamydia trachomatis, an obligate intracellular human pathogen, is one of three bacterial species in the genus Chlamydia. C. trachomatis is a Gram-negative bacteria, therefore its cell wall components retain the counter-stain safranin and appear pink under a light microscope.

The inclusion bodies of Chlamydia trachomatis were first described in 1907, the Chlamydia trachomatis agent was first cultured in the yolk sacs of eggs by Feifan Tang et al in 1957.

Chlamydial infection. Advances in the diagnostic isolation of Chlamydia, including TRIC agent, from the eye, genital tract, and rectum.

C. trachomatis includes three human biovars:

Many, but not all, C. trachomatis strains have an extrachromosomal plasmid.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Cancer stem cells linked to drug resistance

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Low tolerance for pain? The reason may be in your genes

Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual ...

Study says we're over the hill at 24

(Medical Xpress)—It's a hard pill to swallow, but if you're over 24 years of age you've already reached your peak in terms of your cognitive motor performance, according to a new Simon Fraser University study.